Aucubin combined with ADSCs-exos protects TBHP-induced nucleus pulposus cells via TLR4/NF-κB pathway.
10.19540/j.cnki.cjcmm.20230601.703
- Author:
Lei YANG
1
;
Zhao-Yong LI
1
;
Lu MA
2
;
Yan-Tao GUO
1
;
Shao-Feng YANG
1
;
Hui XIONG
2
;
Bo-Yu WU
2
;
Jia-Hao DUAN
1
;
En-Xu LIU
1
;
Chao ZHANG
1
;
Ying NIE
1
;
Long CHEN
1
;
Lin-Quan LIU
2
Author Information
1. the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
2. Hunan University of Chinese Medicine Changsha 410208, China.
- Publication Type:Journal Article
- Keywords:
TLR4/NF-κB signaling pathway;
adipose-derived stem cells-exosomes;
aucubin;
nucleus pulposus cells
- MeSH:
Humans;
NF-kappa B/metabolism*;
Interleukin-10;
Nucleus Pulposus/metabolism*;
Tumor Necrosis Factor-alpha/metabolism*;
Aggrecans/metabolism*;
Toll-Like Receptor 4/metabolism*;
RNA, Messenger/metabolism*
- From:
China Journal of Chinese Materia Medica
2023;48(19):5294-5303
- CountryChina
- Language:Chinese
-
Abstract:
This paper aims to investigate the effects and mechanisms of adipose-derived stem cells-exosomes(ADSCs-exos) toge-ther with aucubin in protecting human-derived nucleus pulposus cells(NPCs) from inflammatory injury, senescence, and apoptosis. The tert-butyl hydroperoxide(TBHP)-induced NPCs were assigned into normal, model, aucubin, ADSCs-exos, and aucubin+ADSCs-exos groups. The cell viability was examined by cell counting kit-8(CCK-8), cell proliferation by EdU staining, cell senescence by senescence-associated-β-galactosidase(SA-β-Gal), and cell cycle and apoptosis by flow cytometry. Enzyme-linked immunosorbent assay was employed to examine the expression of interleukin-1β(IL-1β), IL-10, and tumor necrosis factor-α(TNF-α). Real-time fluorescence quantitative PCR and Western blot were employed to determine the mRNA and protein levels of aggregated proteoglycan(aggrecan), type Ⅱ collagen alpha 1(COL2A1), Toll-like receptor 4(TLR4), and nuclear factor-kappa B(NF-κB). The results showed that compared with the model group, the aucubin or ADSCs-exos group showed enhanced viability and proliferation of NPCs, decreased proportion of G_0/G_1 phase cells, increased proportion of S phase cells, reduced apoptosis and proportion of cells in senescence, lowered IL-1β and TNF-α levels, elevated IL-10 level, down-regulated mRNA and protein levels of TLR4 and NF-κB, and up-regulated mRNA and protein levels of aggrecan and COL2A1. Compared with the aucubin or ADSCs-exos group, the aucubin+ADSCs-exos combination further increased the viability and proliferation of NPCs, decreased the proportion of G_0/G_1 phase cells, increased the proportion of S phase cells, reduced the apoptosis and proportion of cells in senescence, lowered the IL-1β and TNF-α levels, elevated the IL-10 level, down-regulated the mRNA and protein levels of TLR4 and NF-κB, and up-regulated the mRNA and protein levels of aggrecan and COL2A1. In summary, both aucubin and ADSCs-exos could exert protective effects by inhibiting inflammatory responses, reducing apoptosis and senescence of NPCs, improving cell viability and proliferation as well as extracellular matrix synthesis, which may be associated with the inhibition of TLR4/NF-κB signaling pathway activation. The combination of both plays a synergistic role in the protective effects.
